Cannabis, Opioids, and Harm Reduction

Event description
Sponsored by BSAS
No

The Harm Reduction Series is designed to provide caregivers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.

This training will address cannabis use, is it safe? Why do patients find it useful? Is there a benefit to medical cannabis? Can cannabis mitigate the opioid crisis? This training will address the benefits and harms of cannabis and CBD. 

CE/CME credits pending approval. 

Intended audience

The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.

Objectives

Participants will learn the ways in which cannabis can be used to help mitigate the opiate crisis.

Participants will learn the ways in which cannabis cannot be used to help mitigate the opiate crisis.

Participants will have an up to date overview of some of the major harms, benefits of cannabis (and the now overly popular and ubiquitous component of cannabis: CBD), and interesting new studies that have come out (e.g. studies about CBD and addiction -- some indications it may prove helpful for misuse of cannabis, tobacco, stimulants, and opiates).

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.

Details
Presenter
Peter Grinspoon, MD
Event date
to
Attendance mode
Online
Address

United States

Cost
Free
Contact
Tavi Hristova